Ushbu ish iqtibos qilgan ishlar

90 ta ish

Ish: Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety

Unveiling the potential of CLL-1: a promising target for AML therapy
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji +4
Sharh maqola20256 iqtibos
ABI
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini, Valentina Masciale, Giulia Grisendi +8
Sharh maqola20226 iqtibos
ABI
Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
Kaveh Hadiloo, Parsa Mostanadi, Ali Asadzadeh +2
Sharh maqola20256 iqtibos
ABI
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang, Pengfei Shi, Gaichao Zhao +8
Sharh maqola20205 iqtibos
ABI
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Xinyi Xiao, Shengkang Huang, Sifei Chen +4
Sharh maqola20215 iqtibos
ABI
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang +2
Sharh maqola20245 iqtibos
ABI
The clinical landscape of CAR NK cells
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob +1
Sharh maqola20255 iqtibos
ABI
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem, Jorge Mansilla‐Soto, Theodoros Giavridis +6
Maqola20174 iqtibos
ABI
CAR-T Cell Performance: How to Improve Their Persistence?
Gina López-Cantillo, Claudia Urueña, Bernardo Camacho +1
Sharh maqola20224 iqtibos
ABI
The tumor microenvironment’s role in the response to immune checkpoint blockade
Konstantinos Aliazis, Anthos Christofides, Rushil Shah +4
Sharh maqola20254 iqtibos
ABI
Cancer Stem Cell Plasticity – A Deadly Deal
Archana P. Thankamony, Kritika Saxena, Reshma Murali +2
Sharh maqola20204 iqtibos
ABI
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Yin Wang, Yan Liu, Sami N. Malek +2
Maqola20113 iqtibos
ABI
Engineering and Design of Chimeric Antigen Receptors
Sònia Guedan, Hugo Calderón, Avery D. Posey +1
Sharh maqola20183 iqtibos
ABI
Single-cell-guided identification of logic-gated antigen combinations for designing effective and safe CAR therapy
Sanna Madan, Tiangen Chang, Alexandra R. Harris +15
Preprint20253 iqtibos
ABI
Cancer stem cells (CSCs) in cancer progression and therapy
Masoud Najafi, Bagher Farhood, Keywan Mortezaee
Sharh maqola20183 iqtibos
ABI
CAR-T cell combination therapy: the next revolution in cancer treatment
Maysoon Al‐Haideri, Santalia Banne Tondok, Salar Hozhabri Safa +8
Sharh maqolaCAR-T cell therapy researchCancer Cell International20222 iqtibos
ABI
In vivo CAR T cell generation to treat cancer and autoimmune disease
Theresa Hunter, Yanjie Bao, Yan Zhang +37
Maqola20252 iqtibos
ABI
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells
Esther Drent, Renée Poels, Ruud Ruiter +9
Maqola20192 iqtibos
ABI
Therapies targeting cancer stem cells: Current trends and future challenges
Denisa Dragu
Maqola20152 iqtibos
ABI
Targeting the tumour stroma to improve cancer therapy
Kenneth C. Valkenburg, Amber E. de Groot, Kenneth J. Pienta
Sharh maqola20182 iqtibos
ABI
Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications
Shunyao Zhu, Ziyi Luo, Xixi Li +3
Sharh maqola20202 iqtibos
ABI
Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application
Shigeo Saito, Chia‐Chen Ku, Kenly Wuputra +5
Sharh maqola20222 iqtibos
ABI
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Sharh maqola20222 iqtibos
ABI
M6A Demethylase ALKBH5 in Human Diseases: From Structure to Mechanisms
Miaochun Fang, Liwen Ye, Yue Zhu +2
Sharh maqola20252 iqtibos
ABI
CAR-T Cell Therapy: the Efficacy and Toxicity Balance
Karan Chohan, Elizabeth L. Siegler, Saad S. Kenderian
Sharh maqola20232 iqtibos
ABI